Tower Research Capital LLC (Trc) Nuvation Bio Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,214 shares of NUVB stock, worth $15,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,214

Previous 4,306 67.53%

Holding current value

$15,870

Previous $11,000 9.09%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.76 - $3.25 $5,118 - $9,451	2,908 Added 67.53%	7,214 $12,000
Q4 2024 Feb 13, 2025	SELL	$2.01 - $3.01 $8,023 - $12,015	-3,992 Reduced 48.11%	4,306 $11,000
Q3 2024 Nov 14, 2024	SELL	$2.3 - $3.83 $26,622 - $44,332	-11,575 Reduced 58.24%	8,298 $19,000
Q2 2024 Aug 13, 2024	BUY	$2.58 - $3.69 $8,150 - $11,656	3,159 Added 18.9%	19,873 $58,000
Q1 2024 May 15, 2024	BUY	$1.46 - $3.97 $11,882 - $32,311	8,139 Added 94.92%	16,714 $60,000
Q4 2023 Feb 13, 2024	SELL	$0.96 - $1.53 $3,495 - $5,570	-3,641 Reduced 29.81%	8,575 $12,000
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.1 $11,158 - $18,597	8,856 Added 263.57%	12,216 $16,000
Q2 2023 Aug 14, 2023	SELL	$1.56 - $1.84 $48,219 - $56,874	-30,910 Reduced 90.2%	3,360 $6,000
Q1 2023 May 09, 2023	BUY	$1.6 - $2.48 $38,904 - $60,301	24,315 Added 244.25%	34,270 $57,000
Q4 2022 Feb 10, 2023	BUY	$1.68 - $2.5 $2,014 - $2,997	1,199 Added 13.69%	9,955 $19,000
Q3 2022 Nov 10, 2022	SELL	$0.29 - $4.04 $187 - $2,609	-646 Reduced 6.87%	8,756 $20,000
Q2 2022 Aug 15, 2022	BUY	$3.24 - $5.85 $26,451 - $47,759	8,164 Added 659.45%	9,402 $30,000
Q1 2022 May 12, 2022	SELL	$4.6 - $8.83 $6,209 - $11,920	-1,350 Reduced 52.16%	1,238 $7,000
Q4 2021 Feb 14, 2022	SELL	$7.75 - $10.05 $8,602 - $11,155	-1,110 Reduced 30.02%	2,588 $22,000
Q3 2021 Nov 15, 2021	BUY	$7.78 - $10.0 $22,663 - $29,130	2,913 Added 371.08%	3,698 $37,000
Q2 2021 Aug 16, 2021	BUY	$9.22 - $14.48 $1,014 - $1,592	110 Added 16.3%	785 $7,000
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $6,075 - $9,834	675 New	675 $7,000

Others Institutions Holding NUVB

# of Institutions

167

Shares Held

156M

Call Options Held

4.6K

Put Options Held

154K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $478M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Nuvation Bio Inc. Transaction History